All Stories

  1. Wearable Devices for Quantifying Atrial Fibrillation Burden: A Systematic Review and Bayesian Meta-Analysis
  2. Cryoballoon Pulmonary Vein Isolation in Obese Patients with Atrial Fibrillation Compared to Non-Obese Counterparts: A Meta-Analysis
  3. Epicardial Adipose Tissue and Atrial Fibrillation Recurrence following Catheter Ablation: A Systematic Review and Meta-Analysis
  4. Efficacy, Safety and Feasibility of Superior Vena Cava Isolation in Patients Undergoing Atrial Fibrillation Catheter Ablation: An Up-to-Date Review
  5. Advances in the Management of Heart Failure with Reduced Ejection Fraction; The Role of SGLT2is, ARNI, Myotropes, Vericiguat, and Anti-inflammatory Agents: A Mini-review
  6. A call for shorter blanking period, time to get off the ground
  7. Potential Therapeutic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in the Context of Ischemic Heart Failure: A State-of-the-Art Review
  8. Left Distal Radial Artery Access for Coronary Angiography and Interventions: A 12-Month All-Comers Study
  9. Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis
  10. Early arrhythmia recurrence after cryoballoon ablation in atrial fibrillation: A systematic review and meta‐analysis
  11. Colchicine in Cardiovascular Disease: In-Depth Review
  12. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine
  13. Stereotactic Arrhythmia Radioablation as a Novel Treatment Approach for Cardiac Arrhythmias: Facts and Limitations
  14. Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
  15. Molecular Insights in Atrial Fibrillation Pathogenesis and Therapeutics: A Narrative Review
  16. Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations
  17. Impact of myocardial injury on mortality in patients with COVID-19: a meta-analysis
  18. Heroes, politics and media: the unshakable medical practice in the pandemic
  19. Colchicine administered early in acute myocardial infarction: ready, set … go?
  20. Repurposing colchicine’s journey in view of drug-to-drug interactions. A review
  21. Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
  22. The role of cardiology specialties in times of crisis
  23. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
  24. Visually Guided Laser Ablation for Atrial Fibrillation: First experience in Greece
  25. Arteriosclerosis and arterial remodeling; different mechanisms in young adults
  26. Usefulness of a Structured Adult Education Program in Modifying Markers of Cardiovascular Risk After Acute Myocardial Infarction
  27. “TAVI: Valve in valve. A new field for structuralists? Literature review”
  28. Are Drugs Always the Proper Solution to Therapeutic Dilemmas? Non-drug Approaches to the Post-traumatic Stress “Waking Corpse” Syndrome
  29. The Role of Calcium Handling Mechanisms in Reperfusion Injury
  30. The Role of Colchicine in Treating Postoperative and Post–Catheter Ablation Atrial Fibrillation
  31. Colchicum Genus in the Writings of Ancient Greek and Byzantine Physicians
  32. Invasive treatment in peripheral artery disease
  33. Ambulatory Pulse Wave Velocity Monitoring
  34. Permanent pacemaker implantation in octogenarians with unexplained syncope and positive electrophysiologic testing
  35. Remote Ischemic Conditioning and Renal Protection
  36. Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart
  37. Peri-procedural Anticoagulation in Catheter Ablation for Atrial Fibrillation: A Review
  38. Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI
  39. Genetics in the Clinical Decision of Antiplatelet Treatment
  40. Editorial: Antiplatelet and Anticoagulation Treatment in Special Populations
  41. In Vivo Assessment of Atherosclerotic Plaque Neovascularization by Contrast-Enhanced Ultrasound: An Unsolved Mystery?
  42. Impact of balloon aortic valvuloplasty on transcatheter aortic valve implantation with self-expandable valve
  43. Coincidental ganglionated plexus modification during radiofrequency pulmonary vein isolation and post-ablation arrhythmia recurrence
  44. Correlation of CoreValve implantation ‘true cover index’ with short and mid-term aortic regurgitation: A novel index
  45. Dual or Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation? A Systematic Review and Meta-Analysis
  46. Assessment of the vulnerable carotid atherosclerotic plaque using contrast-enhanced ultrasonography
  47. Circulating Erythrocyte Microparticles and the Biochemical Extent of Myocardial Injury in ST Elevation Myocardial Infarction
  48. Mean arterial pressure values calculated using seven different methods and their associations with target organ deterioration in a single-center study of 1878 individuals
  49. Editorial: Bioengineering, Clinical and Therapeutical Trends in Transcatheter Aortic Valve Implantation
  50. Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations
  51. Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations
  52. Jean-Baptiste de Senac's (1693-1770) Important Work on Cardiology and Valvular Disorders
  53. A Preliminary Study on In-Vivo 3-D Imaging of Bioprosthetic Aortic Valve Deformation
  54. Central Blood Pressure Measurement
  55. Essential hypertension in the pathogenesis of age-related macular degeneration
  56. Novel Inflammatory Indices in Aortic Disease
  57. An alternative method of percutaneous mitral valvuloplasty. Matching electrophysiology with interventional cardiology techniques
  58. Antithrombotic therapy in patients undergoing TAVI with concurrent atrial fibrillation. One center experience
  59. Percutaneous Closure of a Large Ascending Aorta Pseudoaneurysm Due to Mediastinitis Using an Amplatzer Occluder Device
  60. Vascular Sealing Implications in Transfemoral Transcatheter Aortic Valve Implantation
  61. Residual platelet reactivity after clopidogrel loading in ST-elevation myocardial infarction patients undergoing a delayed catheterization. Impact on long term clinical events
  62. Implicaciones del sellado vascular en el implante percutáneo transfemoral de válvula aórtica
  63. Percutaneous paravalvular leak closure after TAVI: A demanding approach
  64. Cardiac echo-lab productivity in times of economic austerity
  65. Effect of supine versus sitting position on noninvasive assessment of aortic pressure waveform: a randomized cross-over study
  66. Impact of inflammatory process on left ventricular recovery after Transcatheter Aortic Valve Implantation
  67. Non-invasive 24hour ambulatory monitoring of aortic wave reflection and arterial stiffness by a novel oscillometric device: The first feasibility and reproducibility study
  68. Predictive Factors of Vascular Complications after Transcatheter Aortic Valve Implantation in Patients Treated with a Default Percutaneous Strategy
  69. Troponin levels after TAVI are related to the development of distinct electrocardiographic changes
  70. MicroRNAs in Aortic Disease
  71. Quantitative analysis of carotid plaque vasa vasorum by CEUS and correlation with histology after endarterectomy
  72. Inferior epigastric artery as a landmark for transfemoral TAVI. Optimizing vascular access?
  73. Assessment of Left Atrial Function after Percutaneous Closure of Patent Foramen Ovale
  74. CoreValve deployment during cardiopulmonary resuscitation without angiographic injections guidance
  75. Feasibility and Reproducibility of Noninvasive 24-h Ambulatory Aortic Blood Pressure Monitoring With a Brachial Cuff-Based Oscillometric Device
  76. Effect of transcatheter aortic valve implantation on the ascending aorta’s elasticity
  77. Biomarkers as a Guide of Medical Treatment in Cardiovascular Diseases
  78. Residual Platelet Reactivity After Clopidogrel Loading in Patients With ST-Elevation Myocardial Infarction Undergoing an Unexpectedly Delayed Primary Percutaneous Coronary Intervention
  79. Trans-catheter aortic-valve implantation by the subclavian approach complicated with vessel dissection and transient left-arm paralysis
  80. “Bail out” procedures for malpositioning of aortic valve prosthesis (CoreValve)
  81. A 53-Year-Old Woman With Recurrent Transient Ischemic Attacks
  82. Successful percutaneous aortic valve implantation via a stenotic left subclavian artery access
  83. CoreValve Aortic Bioprosthesis